ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Lionheart Health to Present at the LSI USA '23 Emerging Medtech Summit

Mission Viejo, California, United States - 02-02-2023 (PR Distribution™) -

Lionheart Health, Inc. (a Leonhardt Ventures LLC company), focused on advanced longevity and wellness technologies, announced today that Howard J. Leonhardt, Executive Chairman & Chief Executive Officer, will present at the fourth annual Life Science Intelligence (LSI) USA '23 Emerging Medtech Summit on March 22, 2023 at 4 pm PT (Track 3) in Dana Point, California. The presentation will highlight Lionheart Health's building development pipeline of products designed to not only promote a more youthful appearance but to extend longevity, wellness and healthspan.  With over 700 U.S. patent claims https://patents.justia.com/inventor/howard-j-leonhardt the technology platform is based on applying a convergence of bioelectrics and biologics for regeneration and healing.  The company has patented numerous bioelectric signaling sequences to control specific circulating and tissue protein expressions on demand such as Klotho, SDF1, PDGF, Tropoelastin, NANOG, Sirtuins, Sestrins, COL17A1 and more. 

"Presenting at the LSI Emerging Medtech Summit provides an opportunity to showcase our proprietary products designed to extend longevity and healthspan" stated Howard Leonhardt.  "We look forward to enumerating the multiple potential advantages of our platform technologies which we hope will revolutionize the standard-of-care in fighting back aging and all aging related ailments".

Products to be presented include: 

  1.  BodStim TM www.bodstim.com bioelectric body suit. 
  2.  SkinStim TM www.skin-stim.com for skin rejuvenation.
  3.  HairCell TM www.haircellstim.com for hair regeneration.
  4.  ErectiStim TM www.erectistim.com for male sexual health 
  5.  OrthoStim www.ortho-stim.com for knee osteoarthritis treatment. 

A webcast of the presentation will be available on the Company's websites at www.lionhearthealthstim.com and www.leonhardtventures.com where it will be archived in the News sections.

Those attending the Emerging Medtech Summit whom are interested in scheduling a one-on-one meeting with management, can utilize the meeting portal or can contact Natalie Tinnirello at natalietin602@gmail.com

About the Life Science Intelligence (LSI) USA '23 Emerging Medtech Summit

Being held March 20-23, 2023, at Monarch Beach Resort in Dana Point, CA., the Emerging Medtech Summit has a single mission: to bring together the most innovative medtech startups, active investors, and strategic buyers to deal-make and collaborate about the industry's future.  Learn more at  https://www.lifesciencemarketresearch.com/medtech-summit-2023

About Lionheart Health, Inc.:   

Lionheart Health, Inc. is an emerging leader in longevity and wellness technologies with a deep pipeline of intellectual property and products.  

About Leonhardt Ventures LLC:

Since 1982 Leonhardt Ventures LLC has been inventing, patenting, developing and bringing to market breakthrough medical technology products.  Over 600,000 patients have been treated with Leonhardt inventions to date. 

 For additional information about Leonhardt Ventures LLC see www.leonhardtventures.com 

CONTACT:

Lionheart Health, Inc. 
cs@lionhearthealthstim.com

Lionheart Health, Inc. works in manufacturing partnerships with Mettler Electronics of Anaheim, California and Wiemspro of Spain. 

Media Contacts:

Company Name: Lionheart Health, Inc.
Full Name: Howard J. Leonhardt
Phone: (424) 291-2133
Email Address: Send Email
Website: http://www.leonhardtventures.com

For the original news story, please visit https://www.prdistribution.com/news/lionheart-health-to-present-at-the-lsi-usa-23-emerging-medtech-summit/9517518.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.